Iofina’s CEO Tom Becker Highlights Q3 Strength and Future Expansion Strategies

2 min read | October 21, 2024 03:36 AM PDT | By Team Kalkine Media

Highlights

  • Iofina PLC has reported a year-over-year increase in iodine production, totaling just under 164 metric tons across six operational plants.

  • The company is set to expand its production capabilities with the recent launch of plant IO#10 and the planned construction of IO#11 by year-end.

  • Market demand for iodine and its derivatives is projected to rise by 7% year-on-year, with anticipated increases in average selling prices in the latter half of 2024.

Iofina PLC, (OTC:IOFNF) a leading producer of iodine and iodine derivatives, has announced a robust performance for the third quarter, underscoring the company's ongoing expansion plans. CEO Dr. Tom Becker provided insights into the company’s achievements during an interview with Proactive’s Stephen Gunnion, highlighting the significant increase in iodine production.

The company's production capabilities have expanded with the recent addition of plant IO#10, which came online in September. Across its six operational plants, Iofina produced nearly 164 metric tons of iodine, demonstrating a year-over-year growth in production. The company is also poised to commence construction on IO#11 by the end of the year as part of an aggressive growth strategy aimed at bolstering iodine output.

Dr. Becker remarked on the current iodine market dynamics, noting that demand for iodine and its derivatives is projected to rise by 7% compared to the previous year. He indicated that average selling prices for iodine are anticipated to increase in the latter half of 2024, driven by robust market demand coupled with supply constraints.

Looking beyond IO#11, Iofina is actively pursuing additional expansion initiatives, aiming for a significant increase in iodine production over the coming years. This strategic approach positions the company favorably within the iodine market, capitalizing on the growing demand for iodine in various applications, including pharmaceuticals and industrial processes.

With a clear focus on enhancing production capabilities and responding to market trends, Iofina PLC is set to strengthen its position as a key player in the iodine industry.

 

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.


Sponsored Articles


Investing Ideas

Previous Next